@article{NANDY_BANERJEE_BISWAS_NANDY_MAJUMDER_MUKHERJEE_KUMAR DAS_2021, title={PERCEPTION OF QUALIFIED MEDICAL PRACTITIONERS TOWARD PRESCRIBING IN INTERNATIONAL NON-PROPRIETARY (GENERIC) NAMES – AN OBSERVATIONAL, CROSS-SECTIONAL STUDY AT A TERTIARY CARE HOSPITAL IN INDIA}, volume={14}, url={https://journals.innovareacademics.in/index.php/ajpcr/article/view/39867}, DOI={10.22159/ajpcr.2021.v14i2.39867}, abstractNote={<p><strong>Objectives: </strong>The study was conducted to assess the perception and practice of medical practitioners, working in tertiary care, and teaching institutions in Eastern India, regarding the use of generic (non-proprietary) names while prescribing. The study tried to assess their perception toward using drugs from the National List of Essential Medicine (NLEM), as well.</p> <p><strong>Methods: </strong>An observational, cross-sectional study was conducted. Medical practitioners attached to the institution were considered for the study and those who gave voluntarily consent were included. Hundred participants were interviewed based on convenient random sampling. They were provided with the study questionnaire and the responses were analyzed using Microsoft Excel 2007 using charts and tables.</p> <p><strong>Results: </strong>Majority (43/100) did not feel that generic medicines are as effective as reputed brands, while 32 felt they are of equally effective. About 45% (45/99) felt generics to be equally safe as and 24% (24/99) did not feel so. About 86% considered generics to be cheaper. About 56% did not prefer to substitute with generics in all conditions. About 73% had doubts regarding the quality of production of generics. The decision to use generics was mostly influenced by the lower cost (73%) and by administrative pressure (53%). About 58% felt that the NLEM does not contain all the medicines they would require in practice. About 94% agreed to prescribe more in generics if the quality may be ensured.</p> <p><strong>Conclusion: </strong>Awareness of the NLEM and about generics needs to be improved. Authorities need to ensure the quality of generics and assure the prescribers about it.</p>}, number={2}, journal={Asian Journal of Pharmaceutical and Clinical Research}, author={NANDY, MANAB and BANERJEE, KUSHAL and BISWAS, INDRANIL and NANDY, KAJORI and MAJUMDER, SOUVIK and MUKHERJEE, AYAN and KUMAR DAS, ALAK}, year={2021}, month={Feb.}, pages={134–137} }